CFS
DFTX

CRA Financial Services’s Definium Therapeutics DFTX Stock Holding History

CRA Financial Services’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
+5,846
New +$144K 0.03% 267

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CRA Financial Services's DFTX Position: Q2 2026 in Review

CRA Financial Services opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 5,846 shares worth $275K. The stake represents 0.03% of the portfolio and ranks #267 among its holdings.

361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • CRA Financial Services held 5,846 shares of Definium Therapeutics worth $275K as of Q2 2026.
  • Definium Therapeutics was a new CRA Financial Services position in Q2 2026.
  • Definium Therapeutics made up 0.03% of CRA Financial Services's portfolio in Q2 2026, its #267 holding.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on CRA Financial Services's 13F filing for Q2 2026, filed 24 Jul 2026.